E
Tandem Diabetes Care, Inc.
TNDM
$18.95
$0.76734.22%
E
Sell
8/4/2023Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to E+ from D- on 8/4/2023 due to a large decline in the efficiency index, solvency index and total return index. Debt to equity increased from 0.88 to 0.92, the quick ratio declined from 3.57 to 3.47, and total capital declined 1.27% from $759.15M to $749.52M.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to E+ from D- on 8/4/2023 due to a large decline in the efficiency index, solvency index and total return index. Debt to equity increased from 0.88 to 0.92, the quick ratio declined from 3.57 to 3.47, and total capital declined 1.27% from $759.15M to $749.52M.
D
Sell
5/4/2023Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D- from D on 5/4/2023 due to a significant decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.68 to 0.88, and the quick ratio declined from 4.43 to 3.57.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D- from D on 5/4/2023 due to a significant decline in the total return index, solvency index and volatility index. Debt to equity increased from 0.68 to 0.88, and the quick ratio declined from 4.43 to 3.57.
D
Sell
5/5/2022Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D from C- on 5/5/2022 due to a significant decline in the growth index, volatility index and efficiency index. Earnings per share declined from $0.1661 to -$0.2304, net income declined 236.15% from $10.81M to -$14.72M, and EBIT declined 220.41% from $12.74M to -$15.34M.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D from C- on 5/5/2022 due to a significant decline in the growth index, volatility index and efficiency index. Earnings per share declined from $0.1661 to -$0.2304, net income declined 236.15% from $10.81M to -$14.72M, and EBIT declined 220.41% from $12.74M to -$15.34M.
C
Hold
3/29/2022Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to C- from C on 3/29/2022 due to a noticeable decline in the total return index and growth index. Operating cash flow declined 42.49% from $34.14M to $19.64M.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to C- from C on 3/29/2022 due to a noticeable decline in the total return index and growth index. Operating cash flow declined 42.49% from $34.14M to $19.64M.
C
Hold
8/5/2021Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to C from D on 8/5/2021 due to a substantial increase in the efficiency index, growth index and solvency index. EBIT increased 267.81% from -$3.24M to $5.43M, net income increased 179.46% from -$5.04M to $4.01M, and earnings per share increased from -$0.0808 to $0.06.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to C from D on 8/5/2021 due to a substantial increase in the efficiency index, growth index and solvency index. EBIT increased 267.81% from -$3.24M to $5.43M, net income increased 179.46% from -$5.04M to $4.01M, and earnings per share increased from -$0.0808 to $0.06.
D
Sell
3/19/2021Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D from D+ on 3/19/2021 due to a decline in the volatility index.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D from D+ on 3/19/2021 due to a decline in the volatility index.
D
Sell
3/4/2021Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D+ from D on 3/4/2021 due to a major increase in the growth index, volatility index and valuation index. EBIT increased 1,949.55% from -$1.01M to $18.66M, earnings per share increased from -$0.1529 to $0.2731, and total revenue increased 35.97% from $123.6M to $168.07M.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D+ from D on 3/4/2021 due to a major increase in the growth index, volatility index and valuation index. EBIT increased 1,949.55% from -$1.01M to $18.66M, earnings per share increased from -$0.1529 to $0.2731, and total revenue increased 35.97% from $123.6M to $168.07M.
D
Sell
2/5/2021Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D from D+ on 2/5/2021 due to a decline in the volatility index and valuation index.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D from D+ on 2/5/2021 due to a decline in the volatility index and valuation index.
D
Sell
1/4/2021Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D+ from D on 1/4/2021 due to a noticeable increase in the volatility index and valuation index.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D+ from D on 1/4/2021 due to a noticeable increase in the volatility index and valuation index.
D
Sell
9/26/2019Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D from D- on 9/26/2019 due to a significant increase in the solvency index, total return index and growth index. Operating cash flow increased 186.52% from -$4.12M to $3.57M, earnings per share increased from -$0.398 to -$0.026, and EBIT increased 83.04% from -$11M to -$1.87M.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D from D- on 9/26/2019 due to a significant increase in the solvency index, total return index and growth index. Operating cash flow increased 186.52% from -$4.12M to $3.57M, earnings per share increased from -$0.398 to -$0.026, and EBIT increased 83.04% from -$11M to -$1.87M.
D
Sell
5/15/2018Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D- from E+ on 5/15/2018 due to an increase in the volatility index, total return index and valuation index.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D- from E+ on 5/15/2018 due to an increase in the volatility index, total return index and valuation index.
E
Sell
4/30/2018Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to E+ from D- on 4/30/2018 due to a large decline in the growth index, valuation index and solvency index. Debt to equity increased from -2.63 to 6.45, EBIT declined 61.59% from -$9.58M to -$15.49M, and earnings per share declined from -$1.2314 to -$1.817.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to E+ from D- on 4/30/2018 due to a large decline in the growth index, valuation index and solvency index. Debt to equity increased from -2.63 to 6.45, EBIT declined 61.59% from -$9.58M to -$15.49M, and earnings per share declined from -$1.2314 to -$1.817.
D
Sell
4/10/2018Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D- from E+ on 4/10/2018 due to a substantial increase in the growth index and valuation index. Earnings per share increased from -$3.0896 to -$1.2314, total revenue increased 49.22% from $27M to $40.3M, and operating cash flow increased 38.79% from -$19.02M to -$11.64M.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D- from E+ on 4/10/2018 due to a substantial increase in the growth index and valuation index. Earnings per share increased from -$3.0896 to -$1.2314, total revenue increased 49.22% from $27M to $40.3M, and operating cash flow increased 38.79% from -$19.02M to -$11.64M.
E
Sell
7/13/2016Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to E+ from D- on 7/13/2016 due to a substantial decline in the growth index, solvency index and total return index. Debt to equity increased from 0.47 to 0.96, EBIT declined 71.46% from -$11.22M to -$19.24M, and earnings per share declined from -$0.4008 to -$0.6762.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to E+ from D- on 7/13/2016 due to a substantial decline in the growth index, solvency index and total return index. Debt to equity increased from 0.47 to 0.96, EBIT declined 71.46% from -$11.22M to -$19.24M, and earnings per share declined from -$0.4008 to -$0.6762.
D
Sell
3/11/2016Downgrade
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D- from D on 3/11/2016 due to a large decline in the volatility index, total return index and efficiency index. Total capital declined 7.54% from $100.73M to $93.14M.
Tandem Diabetes Care, Inc. (TNDM) was downgraded to D- from D on 3/11/2016 due to a large decline in the volatility index, total return index and efficiency index. Total capital declined 7.54% from $100.73M to $93.14M.
D
Sell
12/10/2014Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D from D- on 12/10/2014 due to an increase in the efficiency index and volatility index. Net income increased 3.66% from -$19.2M to -$19.9M.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D from D- on 12/10/2014 due to an increase in the efficiency index and volatility index. Net income increased 3.66% from -$19.2M to -$19.9M.
D
Sell
8/1/2014Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D- from E+ on 8/1/2014 due to an increase in the growth index and efficiency index. Total revenue increased 27.14% from $8.07M to $10.25M.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to D- from E+ on 8/1/2014 due to an increase in the growth index and efficiency index. Total revenue increased 27.14% from $8.07M to $10.25M.
E
Sell
5/1/2014Upgraded
Tandem Diabetes Care, Inc. (TNDM) was upgraded to E+ from E on 5/1/2014 due to a significant increase in the solvency index, total return index and valuation index. The quick ratio increased from 1.35 to 9.23, and debt to equity declined from 11.4 to 0.25.
Tandem Diabetes Care, Inc. (TNDM) was upgraded to E+ from E on 5/1/2014 due to a significant increase in the solvency index, total return index and valuation index. The quick ratio increased from 1.35 to 9.23, and debt to equity declined from 11.4 to 0.25.
NASDAQ
03/14/2025 11:41AM Eastern
Quotes delayed
